Researchers at Johns Hopkins Medicine identified a protein – known as factor D – that appears essential to the inflammatory process of SARS-CoV-2, the virus that causes Covid-19.
Vaccinex Inc. will pair the company’s lead asset pepinemab with Merck & Co.’s vaunted checkpoint inhibitor Keytruda.
Scientists succeeded in reviving microbes retrieved from sediment deep under the seafloor in the heart of the South Pacific that had survived in a dormant state for 101.5 million years in research illustrating the resiliency of life on Earth.
San Diego-based Engrail Therapeutics launched with $32 million in a Series A financing round that was solely funded by Nan Fung Life Sciences (NFLS).
One day, cell and gene therapies will be as common as small molecules and antibody-based therapies are today, according to panelists at BIO 2020.
Switzerland’s Roche acquired genetic sequencing company Stratos Genomics for an undisclosed amount.
For some time, there has been speculation that glucose metabolism was associated with Alzheimer’s disease, with some researchers going so far as to call Alzheimer’s diabetes type 3. Researchers with the National Institutes of Health’s National Institute on Aging conducted the largest study so far on proteins related to Alzheimer’s and identified proteins and biological processes that regulate glucose metabolism that are associated with Alzheimer’s. The study was published in the journal Nature Medicine.
Flagship Pioneering launched Cellarity, focused on studying and altering cell behaviors as a means of drug development.
Researchers at The Scripps Research Institute in Florida published a study in the journal Science describing a newly discovered biological system that manages how cells respond to exposure to opioids.
Researchers with the Hubrecht Institute in Utrecht, Netherlands and Radboud University in Nijmegen, Netherlands, developed a human model using organoids to evaluate the function of specific genes commonly mutated in liver cancer.